158 related articles for article (PubMed ID: 38504385)
21. Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1.
Hoshino Y; Nishida J; Katsuno Y; Koinuma D; Aoki T; Kokudo N; Miyazono K; Ehata S
Am J Pathol; 2015 May; 185(5):1457-70. PubMed ID: 25769430
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.
Singh P; Wig JD; Srinivasan R; Radotra BD
Indian J Cancer; 2011; 48(2):170-4. PubMed ID: 21768661
[TBL] [Abstract][Full Text] [Related]
23. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9.
Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R
Cancer Lett; 2017 Dec; 410():68-81. PubMed ID: 28947139
[TBL] [Abstract][Full Text] [Related]
24. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
Liang C; Shi S; Qin Y; Meng Q; Hua J; Hu Q; Ji S; Zhang B; Xu J; Yu XJ
Gut; 2020 May; 69(5):888-900. PubMed ID: 31611300
[TBL] [Abstract][Full Text] [Related]
25. Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.
Fabian A; Stegner S; Miarka L; Zimmermann J; Lenk L; Rahn S; Buttlar J; Viol F; Knaack H; Esser D; Schäuble S; Großmann P; Marinos G; Häsler R; Mikulits W; Saur D; Kaleta C; Schäfer H; Sebens S
Cancer Lett; 2019 Jul; 453():95-106. PubMed ID: 30930235
[TBL] [Abstract][Full Text] [Related]
26. SMAD4 Y353C promotes the progression of PDAC.
Wang Z; Li Y; Zhan S; Zhang L; Zhang S; Tang Q; Li M; Tan Z; Liu S; Xing X
BMC Cancer; 2019 Nov; 19(1):1037. PubMed ID: 31684910
[TBL] [Abstract][Full Text] [Related]
27. SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization.
Dai C; Rennhack JP; Arnoff TE; Thaker M; Younger ST; Doench JG; Huang AY; Yang A; Aguirre AJ; Wang B; Mun E; O'Connell JT; Huang Y; Labella K; Talamas JA; Li J; Ilic N; Hwang J; Hong AL; Giacomelli AO; Gjoerup O; Root DE; Hahn WC
Cell Rep; 2021 Jul; 36(4):109443. PubMed ID: 34320363
[TBL] [Abstract][Full Text] [Related]
28. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
Ganguly K; Krishn SR; Rachagani S; Jahan R; Shah A; Nallasamy P; Rauth S; Atri P; Cox JL; Pothuraju R; Smith LM; Ayala S; Evans C; Ponnusamy MP; Kumar S; Kaur S; Batra SK
Cancer Res; 2021 Jan; 81(1):91-102. PubMed ID: 33127746
[TBL] [Abstract][Full Text] [Related]
29. Loss of canonical Smad4 signaling promotes KRAS driven malignant transformation of human pancreatic duct epithelial cells and metastasis.
Leung L; Radulovich N; Zhu CQ; Wang D; To C; Ibrahimov E; Tsao MS
PLoS One; 2013; 8(12):e84366. PubMed ID: 24386371
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
[TBL] [Abstract][Full Text] [Related]
31. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
[TBL] [Abstract][Full Text] [Related]
32. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.
Mortoglou M; Miralles F; Arisan ED; Dart A; Jurcevic S; Lange S; Uysal-Onganer P
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163198
[TBL] [Abstract][Full Text] [Related]
33. Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion
Li K; Zhang Z; Mei Y; Yang Q; Qiao S; Ni C; Yao Y; Li X; Li M; Wei D; Fu W; Guo X; Huang X; Yang H
Theranostics; 2021; 11(7):3196-3212. PubMed ID: 33537082
[TBL] [Abstract][Full Text] [Related]
34. Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma.
Mahadevan KK; Arora KS; Amzallag A; Williams E; Kulkarni AS; Fernandez-Del Castillo C; Lillemoe KD; Bardeesy N; Hong TS; Ferrone CR; Ting DT; Deshpande V
Mod Pathol; 2019 Jun; 32(6):844-854. PubMed ID: 30683911
[TBL] [Abstract][Full Text] [Related]
35. The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinoma.
Sunamura M; Lefter LP; Duda DG; Morita R; Inoue H; Yokoyama T; Yatsuoka T; Abe T; Egawa S; Furukawa T; Fukushige S; Oshimura M; Horii A; Matsuno S
Pancreas; 2004 Apr; 28(3):311-6. PubMed ID: 15084978
[TBL] [Abstract][Full Text] [Related]
36. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
[TBL] [Abstract][Full Text] [Related]
37. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C
Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238
[TBL] [Abstract][Full Text] [Related]
38. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
39. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.
Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F
Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
